Alzheimer’s Association International Conference 2021 Highlights
It was refreshing to see many familiar faces in Denver for AAIC 2021. Recruitment Partners is excited about the partnerships that will develop in time from our meetings there. If we were not able to connect, please email us to setup a call to discuss how we can improve the pace of your trial.
Recruitment Partners was also very proud to have our work with Dr. Mary Sano and team of Icahn School of Medicine and Dr. Sharon Bragman and team of SUNY Upstate on enhancing research participation in underrepresented groups showcased in a scientific poster session at the conference. Learn more here.
Did you miss the conference? Here are 5 key learnings from the recent Alzheimer’s Association International Conference (AAIC).
- The Long-Term Cognitive Impact of COVID-19 on cognitive health. Initial research suggests that some older adults may suffer lasting cognitive impairment which may include memory issues after recovery from COVID-19 infection.
- Improved Air Quality May Decrease Dementia Risk. Multiple studies show that air pollution build up has been linked to increased risk of ADRD. Improving air quality may improve cognitive function.
- Transgender Adults Experience Higher Rates of Subjective Cognitive Decline. Research has found that transgender adults are nearly twice as likely to report subjective cognitive decline. Further, Transgender adults have higher risk of depression which can lead to higher risks for ADRD.
- Global Prevalence of Alzheimer’s Predicted to Triple by 2050. New data forecasts global dementia prevalence will triple to 152 million by 2050 as a result of upward trends in smoking, high body mass index (BMI) and high blood sugar.
- Clinical Trial Diversity is Crucial to the Success of Clinical Trials. Minorities have historically been underrepresented in clinical ADRD research and these are the very populations at a higher risk for developing ADRD.
For more information, visit here.
Race, Ethnicity, and Dementia
Minority populations are at a higher risk for developing ADRD but are significantly underrepresented in clincal trials. The first Black Alzheimer’s brain study launches in Dallas-Fort Worth to study why Black people are disproportionately affected by Alzheimer’s disease.
People of color want to participate in Alzheimer’s research. The NIA has a new tool to make it happen. The now publically available tool, Outreach Pro, includes resources to customize websites, handouts, videos, social media outreach and other forms of engagement for researches to connect with underrepresented groups. Initially available in English and Spanish for African American and Hispanic/Latino communities, the NIA is also working on developing materials in multiple languages this fall for Asian Americans and Pacific Islanders, and next year for American Indian and Alaska Native groups.
How well will Biogen’s drug Aduhelm perform in the real world? This study is set to find out.
Researchers will soon enroll participants into a new phase 4 trial which will explore how the new drug Aduhelm impacts healthcare resources, quality of life, and overall disease burden. The study will enroll people with mild cognitive impairment or mild dementia, will have a diversity focus enrolling at least 500 African American and 500 Hispanic people, and will include people who may not typically qualify for clinical trials, like those with diabetes, high blood pressure and cancer. Read more about the ICARE AD-US study here.
CVS Health Introduces Clinical Trial Services
CVS has introduced on-site clinical trials with the goal of driving greater access to clinical trials. The initiative seeks to deliver a more efficient and convenient experience to improve participant enrollment and retention across diverse communities.
Read more here.
Do you have, or are you a caregiver of a person diagnosed with AD? Do you live in the San Diego area? You may benefit from participating in the UCSD Alzheimer’s Disease Research Study. You or your loved one will receive an FDA approved treatment for AD free of cost. To learn more, CLICK HERE to view the UCSD Study flyer.
My Clinical Trial Center Video Game
Not only a great tool to educate young people on clinical trials, how they work, and why they are so important, but also a beautiful representation of community-based participatory research (CBPR). CBPR recognizes community members as experts in the research about them, and it actively integrates their opinions and suggestions into all aspects of the research process.
What’s Happening in the Alzheimer’s Field?
Amazonian Tribe May Hold Key to Having Highly Healthy Brain, Avoiding Dementia
While brain scans show that the Tsimane indigenous people of the Bolivian Amazon have similar levels of brain inflammation as Westerners, their brains stay healthier. The researchers behind the finding believe that, as the Tsimane don’t have access to modern medicine like their Western counterparts, their diet and lifestyle is the most likely explanation. The tribe is highly physically active and eat a high-fiber diet, including vegetables, fish, and lean meat. Their brains likely experience far less brain atrophy than Westerners as they age. Atrophy correlates with risk of cognitive impairment, functional decline, and dementia.
For more information, visit here.
$2M NIH Grant Goes to Study of Infection’s Role in Alzheimer’s
The National Institutes of Health (NIH) has awarded a $2-million grant to support research into the role of infections in the development of Alzheimer’s disease. The study tests the hypothesis that infection can be one of the factors that triggers Alzheimer’s disease, and specifically sepsis and meningitis. If the link between infection and Alzheimer’s disease is established, more attention can be given to these diseases in the interest of avoiding the onset of dementia. Read more about the study here.
Missing Out on Sleep May Increase Dementia Risk
Sleeping gives the brain a chance to clean up. When we’re asleep, there’s an increased flow of fluid through the brain, and this is hypothesized to clear out waste products. Inadequate sleep is also associated with atherosclerosis, hypertension, obesity, diabetes and depression – all of which are risk factors for Alzheimer’s disease and other dementias.
Learn more here.
Music Can Have a Powerful Effect on those with ADRD
Music can have a beneficial effect on people with Alzherimer’s and dementia. Music can help in a variety of ways including: reduce anxiety, stress, loneliness and depression, bring a sense of familiarity, safety, and comfort, tap into emotional memory and long-term memory, and more.
Learn more here.
Interested in learning how RP makes connections between care communities and researchers?
Email us today for more information and to join or mailing list!